Search Results

Detection and Management of Geographic Atrophy Secondary to Age-Related Macular Degeneration Using Noninvasive Retinal Images and Artificial Intelligence: Systematic Review.

• Authors : Shi N; Department of Eye Function Laboratory, Eye Hospital China Academy of Chinese Medical Sciences, No.33 Lugu Road, Shijingshan District, Beijing, 100040, China, +86 010-68683451.; Li J

Subjects: Artificial Intelligence* ; Geographic Atrophy*/Geographic Atrophy*/Geographic Atrophy*/diagnostic imaging ; Geographic Atrophy*/Geographic Atrophy*/Geographic Atrophy*/etiology

• Source: Journal of medical Internet research [J Med Internet Res] 2025 Nov 21; Vol. 27, pp. e81328. Date of Electronic Publication: 2025 Nov 21.Publisher: JMIR Publications Country of Publication: Canada NLM ID: 100959882 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration

• Source: A Phase I/IIa Trial for Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic

Record details

A Study to Test Whether BI 771716 Helps People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy (VERDANT)

• Source: Randomized, Double-masked, Active-controlled, Multicenter Study to Evaluate Efficacy and Safety of Two Regimens of Intravitreal BI 771716 Against Pegcetacoplan in Participants With

Record details

Evaluation of Kamuvudine-8 in Subjects With Geographic Atrophy (K8 for GA)

• Authors : Inflammasome Therapeutics; Michelle Abou-Jaoude, Assistant Professor

• Source: A Non-Randomized, Open Label, Safety and Efficacy Study Evaluating Kamuvudine-8 (K8) for the Treatment of Patients With Geographic Atrophy

Record details

SGLT2 Inhibitors in Geographic Atrophy

• Authors : Rajendra S. Apte, Principal Investigator; Paul A. Cibis Distinguished Professor of Ophthalmology and Visual Sciences; Vice Chair for Innovation and Translation

• Source: Efficacy of Dapagliflozin in the Progression of Geographic Atrophy Secondary to Age-Related Macular DegenerationYao S, Zheng F, Yu

Record details

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy (SIENNA)

• Source: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Phase 3 Study of the Efficacy, Safety, and Tolerability of Subcutaneously Administered Pozelimab in Combination With Cemdisiran or

Record details

A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy

• Source: A Non-interventional, Observational Study to Evaluate Treatment Patterns and Safety of Avacincaptad Pegol (ACP/IZERVAY™) in Routine Clinical Practice in Patients With

Record details

A Study to Test Different Doses of BI 1584862 in People With a Distinct Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy

• Source: JADE: Phase II Trial in Patients With Geographic Atrophy: A Randomized, Double-masked, Placebo-controlled, Dose-finding Study to Evaluate

Record details

Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy (ArMaDa)

• Source: A Phase 1/2 Study to Assess the Safety And Efficacy Of OCU410 For Geographic Atrophy Secondary To Dry Age-Related Macular Degeneration

Record details

A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) (SIGLEC)

• Source: A Single and Multiple Dose Study to Evaluate Safety, Pharmacokinetics, and Treatment Effect of Intravitreal AVD-104 in Participants With Geographic

Record details